ELF Stock Analysis: ELF Beauty | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 6.122m USD | 12M Return: -25.3% | US26856L1035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 131M
EPS Trend: 3.2%
Qual. Beats: 1
Rev. Trend: 96.8%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 10 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
e.l.f. Beauty, Inc. is a global beauty company that designs and sells cosmetics and skin care products across eye, lip, face, and skin care categories. The company markets its products under multiple brand names, including e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Rhode, reflecting a multi-brand portfolio strategy common within the personal care products industry.
The company distributes its products through two main channels: national and international retailers (wholesale) and direct-to-consumer e-commerce, a hybrid model that allows it to reach both brick-and-mortar shoppers and online customers. This dual-channel approach is typical of mass-market beauty brands seeking broad consumer reach.
Founded in 2004 and headquartered in Oakland, California, the company was originally called J.A. Cosmetics Holdings, Inc. before adopting its current name in April 2016. It trades on the NYSE under the ticker ELF and is classified within the Consumer Staples sector under the Personal Care Products sub-industry.
- Rhode brand acquisition expands skincare and category reach
- International segment revenue grows double digits on new retailer wins
- Gross margin pressure persists from tariffs and elevated promotional spending
| Net Income: 59.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: 29.63% < 20% (prev 31.11%; Δ -1.48% < -1%) |
| CFO/TA 0.12 > 3% & CFO 296.9m > Net Income 59.6m |
| Net Debt (674.7m) to EBITDA (221.9m): 3.04 < 3 |
| Current Ratio: 2.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.7m) vs 12m ago 3.56% < -2% |
| Gross Margin: 74.44% > 18% (prev 70.67%; Δ 3.77% > 0.5%) |
| Asset Turnover: 93.34% > 50% (prev 102.1%; Δ -8.78% > 0%) |
| Interest Coverage Ratio: 2.82 > 6 (EBIT TTM 129.6m / Interest Expense TTM 46.0m) |
| A: 0.21 (Total Current Assets 859.8m - Total Current Liabilities 337.7m) / Total Assets 2.46b |
| B: -0.04 (Retained Earnings -89.3m / Total Assets 2.46b) |
| C: 0.07 (EBIT TTM 129.6m / Avg Total Assets 1.89b) |
| D: 0.90 (Book Value of Equity 1.17b / Total Liabilities 1.29b) |
| Altman-Z'' = 2.69 = A |
| DSRI: 0.77 (Receivables 174.5m/173.4m, Revenue 1.76b/1.34b) |
| GMI: 0.95 (GM 70.67% / 74.44%) |
| AQI: 1.24 (AQ_t 0.63 / AQ_t-1 0.51) |
| SGI: 1.31 (Revenue 1.76b / 1.34b) |
| TATA: -0.10 (NI 59.6m - CFO 296.9m) / TA 2.46b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of October 08, 2026, the stock is trading at USD 105.03 with a total of 1,301,240 shares traded. Over the past week, the price has changed by +4.02%, over one month by +0.69%, over three months by +39.41% and over the past year by -25.30%.
Current recommended Stop Loss: 96.00 (which is 8.6% or 2.3 ATR below the current price).
ELF Beauty has received a consensus analysts rating of 4.28. Therefore, it is recommended to buy ELF.
- StrongBuy: 11
- Buy: 1
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 104.1 | -0.9% |
P/E Trailing = 105.8674
P/E Forward = 35.2113
P/S = 3.4743
P/B = 5.0876
P/EG = 1.3707
Revenue TTM = 1.76b USD
EBIT TTM = 129.6m USD
EBITDA TTM = 221.9m USD
Long Term Debt = 802.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 1.02b USD (from shortLongTermDebtTotal, last quarter) + Leases 97.3m
Net Debt = 674.7m USD (calculated: Debt 1.02b - CCE 344.2m)
Enterprise Value = 6.80b USD (6.12b + Debt 1.02b - CCE 344.2m)
Interest Coverage Ratio = 2.82 (Ebit TTM 129.6m / Interest Expense TTM 46.0m)
EV/FCF = 24.26x (Enterprise Value 6.80b / FCF TTM 280.2m)
FCF Yield = 4.12% (FCF TTM 280.2m / Enterprise Value 6.80b)
FCF Margin = 15.90% (FCF TTM 280.2m / Revenue TTM 1.76b)
Net Margin = 3.38% (Net Income TTM 59.6m / Revenue TTM 1.76b)
Gross Margin = 74.44% ((Revenue TTM 1.76b - Cost of Revenue TTM 450.5m) / Revenue TTM)
Gross Margin QoQ = 83.20% (prev 72.66%)
Tobins Q-Ratio = 2.76 (Enterprise Value 6.80b / Total Assets 2.46b)
Interest Expense / Debt = 4.51% (Interest Expense 46.0m / Debt 1.02b)
Taxrate = 28.74% (24.0m / 83.6m)
NOPAT = 92.4m (EBIT 129.6m * (1 - 28.74%))
Current Ratio = 2.55 (Total Current Assets 859.8m / Total Current Liabilities 337.7m)
Debt / Equity = 0.87 (Debt 1.02b / totalStockholderEquity, last quarter 1.17b)
Debt / EBITDA = 3.04 (Net Debt 674.7m / EBITDA 221.9m)
Debt / FCF = 2.41 (Net Debt 674.7m / FCF TTM 280.2m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.16% (Net Income 59.6m / Total Assets 2.46b)
RoE = 5.18% (Net Income TTM 59.6m / Total Stockholder Equity 1.15b)
RoCE = 6.64% (EBIT 129.6m / Capital Employed (Equity 1.15b + L.T.Debt 802.0m))
RoIC = 4.47% (NOPAT 92.4m / Invested Capital 2.06b)
WACC = 10.70% (E(6.12b)/V(7.14b) * Re(11.95%) + D(1.02b)/V(7.14b) * Rd(4.51%) * (1-Tc(0.29)))
Discount Rate = 11.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 70.26 | Cagr: 0.94%
[DCF] Terminal Value 70.75% ; FCFF base≈222.1m ; Y1≈254.6m ; Y5≈374.7m
[DCF] Fair Price = 56.01 (EV 3.98b - Net Debt 674.7m = Equity 3.31b / Shares 59.0m; r=10.70% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 3.19 | EPS CAGR: 0.26% | SUE: 4.0 | # QB: 1
Revenue Correlation: 96.84 | Revenue CAGR: 29.94% | SUE: 2.73 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.58 | Chg30d=-1.62% | Revisions=-40% | Analysts=19
EPS next Quarter (2026-12-31): EPS=0.85 | Chg30d=+1.31% | Revisions=+17% | Analysts=19
EPS current Year (2027-03-31): EPS=3.63 | Chg30d=+0.53% | Revisions=+0% | GrowthEPS=+15.9% | GrowthRev=+20.3%
EPS next Year (2028-03-31): EPS=3.87 | Chg30d=+1.05% | Revisions=+29% | GrowthEPS=+6.6% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +6% (up=7, down=6)